Ocugen Inc. (NASDAQ:OCGN) does about 34.60M shares in volume on a normal day but saw 18846098 shares change hands in Monday trading. The company now has a market cap of 47.70M USD. Its current market price is $0.35, marking a decrease of -12.95% compared to the previous close of $0.40. The 52 week high reached by this stock is $17.40 whilst the lowest price level in 52 weeks is $0.17. The script in recent trading has seen the stock touch a high of $0.3949 and a low of $0.296.

Ocugen Inc. (OCGN) has a 20-day trading average at $0.4975 and the current price is -98.00% off the 52-week high compared with 104.82% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3859 and its 200-day simple moving average is $0.4002. If we look at the stock’s price movements over the week, volatility stands at 13.29%, which decreases to 12.73% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.64 to suggest the stock is neutral.

2 analysts observing the Ocugen Inc. (OCGN) stock have set the 12-month price targets for the company’s shares at between $0.70 and $0.70. The median price target is 50.0% away from the current levels at $0.70.

FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Overweight and Wall Street’s advice is for investors to Moderate Buy the stock.

The current price level is -31.26%, -9.21%, and -13.24% away from its SMA20, SMA50, and SMA200 respectively, with the OCGN price moving above the 50-day SMA on August 31. Ocugen Inc. (OCGN) stock is down -15.07% over the week and -32.40% over the past month. Its price is -33.04% year-to-date and -97.58% over the past year.

The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.19 below consensus estimates by -$0.16. OCGN’s earnings per share are forecast to grow by 77.80% this year and 60.70% over next year.

Its 12-month price target is $0.70. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $0.70, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $0.70.

Outstanding shares total 135.01M with insiders holding 8.15% of the shares and institutional holders owning 11.98% of the company’s common stock. The company has a return on equity of -614.70%. The beta has a value of 2.69. Price to book ratio is 1.93 and price to sales ratio is 1119.27.

According to a U.S. Securities and Exchange Commission filing, Vanguard Extended Market Index Fu has reduced its position in Ocugen Inc. (OCGN) to 329,385 shares, mirroring a recent drop by 0.00%. Vanguard Extended Market Index Fu dumped 0.0 shares of Ocugen Inc. common stock bringing its total worth to about $0.17 million at the end of recent close, SEC documents show. Vanguard Extended Market Index Fu isn’t the only investment manager who changed stakes and is followed by Fidelity Extended Market Index Fu, which sold off 0.0 shares to end up with 194,488 shares worth $0.1 million. USAA Extended Market Index Fund raise their holdings by 138.08% in the company over the course of the most recent quarter. It now holds a 0.01% position in Ocugen Inc. thanks to 16494.0 shares amounting to $8494.0.